In vitro and in vivo characterization of [64Cu][Cu(elesclomol)] as a novel theranostic agent for hypoxic solid tumors.
Eur J Nucl Med Mol Imaging
; 50(12): 3576-3588, 2023 Oct.
Article
in En
| MEDLINE
| ID: mdl-37382663
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Eur J Nucl Med Mol Imaging
Journal subject:
MEDICINA NUCLEAR
Year:
2023
Document type:
Article
Affiliation country:
Norway
Country of publication:
Germany